Mac-1 (CR3) and Fc gamma receptors in immune-mediated neutrophil cytotoxicity
Mac-1 (CR3) 和 Fc gamma 受体在免疫介导的中性粒细胞细胞毒性中的作用
基本信息
- 批准号:8423361
- 负责人:
- 金额:$ 35.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-09-30 至 2014-12-31
- 项目状态:已结题
- 来源:
- 关键词:4-ethoxymethylene-2-phenyl-2-oxazoline-5-oneAdhesivesAntibodiesAntigen-Antibody ComplexAttenuatedAutoimmune DiseasesAutoimmune ProcessAutoimmune hemolytic anemiaBindingBiochemicalBiological AssayBullous PemphigoidC3biClinical TrialsComplementCoupledCutaneous InvolvementDataDepositionDermalDiseaseEnsureErythrocytesExhibitsFamilyFamily memberFundingGenerationsGlomerulonephritisGlucansGoalsGrantGuanineGuanine Nucleotide Exchange FactorsGuanosine Triphosphate PhosphohydrolasesHemolytic AnemiaHemorrhagic VasculitisHost DefenseHost Defense MechanismITAMIgG ReceptorsImmuneImmunityImmunocompromised HostImmunoglobulin GImmunosuppressionIn VitroInfectionInflammatoryInflammatory ResponseInjuryIntegrinsLeadLeukocyte ElastaseLinkMacrophage-1 AntigenMediatingModelingMolecularMycosesMyelogenousNADPH OxidaseNeutrophil InfiltrationOrganPTK2 genePathologyPathway interactionsPhagocytesPhagocytosisPhagosomesPharmaceutical PreparationsPhospholipase CPhospholipase DPhosphorylationPhosphotransferasesPhysiologicalPlayPredispositionProcessProtein FamilyProtein Kinase CProtein Tyrosine KinaseProteinsProteomicsReactive Oxygen SpeciesRegulationRelative (related person)Respiratory BurstRheumatismRoleShwartzman PhenomenonSignal PathwaySignal TransductionSignaling MoleculeTherapeuticTissuesTransducersTreatment EfficacyVariantVasculitisbasecombatcomparativecytotoxiccytotoxicitydectin 1designglomerular basement membranehuman SYK proteinhuman diseasein vitro Assayin vivoin vivo Modelinterestmacrophagemicrobialnatalizumabneutrophilneutrophil cytosol factor 40Kopsonin receptorparticleprotein functionpublic health relevancerac GTP-Binding Proteinsreceptorresponserhorho GTP-Binding Proteinsskin disordersrc-Family Kinasestherapeutic developmenttherapeutic targettooltraffickinguptake
项目摘要
DESCRIPTION (provided by applicant): Phagocytic functions of neutrophils and macrophages are essential for immunity to microbial infection, but can also contribute to tissue injury during inflammatory responses and autoimmune pathologies. The overall goal of this application is to continue to extend our understanding of the molecular basis of phagocyte cytotoxicity focusing on two major opsonic receptors on phagocytes, Fc?Rs (receptors for IgG immune complex) and the ¿2 integrin Mac-1 (receptor for complement fragment iC3b). Major accomplishments of the past 4 years were to 1) demonstrate that Vav proteins, exchange factor for Rho GTPase family members are required for several Mac-1 and Fc?R mediated adhesive functions in neutrophils, 2) identify Vav proteins as the major signal transducers of NADPH oxidase activation following Fc?R engagement, through regulation of Rac GTPases and phosphorylation of the NADPH oxidase p40phox, 3) present in vivo evidence that neutrophil Fc?R dependent but not complement dependent tissue injury requires Vav and Rac proteins, 4) define a role for Mac-1 in triggering neutrophil elastase release and subsequent hemorrhagic vasculitis in vivo, through activation of the src and syk kinases, and 5) demonstrate a critical role for Mac-1 on neutrophils in two additional complement dependent models, bullous pemphigoid and thrombotic glomerulonephritis. The current application builds on these discoveries. The objective of Aim I is to delineate mechanisms of neutrophil phagocytosis that are relevant for complement C3 mediated tissue injury and host defense. In particular we will examine both signals that lead to Mac-1 binding of its target and those that link Mac-1 to downstream effector functions. In Aim II, we will further delineate mechanisms of Vav mediated regulation of the NADPH oxidase following Fc?R engagement in neutrophils and macrophages. We will also clarify the role of Vav and Rac in IgG or complement mediated phagocytosis in macrophages in models of autoimmune hemolytic anemia. We anticipate that the completion of our aims should lead to a better understanding of signaling pathways that link opsonic receptors to specific phagocyte cytotoxic functions. This may aid in the design of therapeutics to selectively target pathways responsible for tissue damage in inflammatory and autoimmune disorders while minimizing effects on host defense.
描述(由申请人提供):中性粒细胞和巨噬细胞的吞噬功能对于微生物感染的免疫至关重要,但也可能导致炎症反应和自身免疫病理过程中的组织损伤。本申请的总体目标是继续扩展我们对微生物感染的理解。吞噬细胞细胞毒性的分子基础,重点关注吞噬细胞上的两种主要调理受体:Fc?R(IgG 免疫复合物的受体)和 ¿ 2 整合素 Mac-1(补体片段 iC3b 的受体) 过去 4 年的主要成就是 1) 证明 Vav 蛋白(Rho GTPase 家族成员的交换因子)是多种 Mac-1 和 Fc?R 介导的粘附功能所必需的。在中性粒细胞中,2) 通过调节 Rac GTPases 和 Fc?R 接合,确定 Vav 蛋白是 Fc?R 参与后 NADPH 氧化酶激活的主要信号转导子NADPH 氧化酶 p40phox 的磷酸化,3) 体内证据表明中性粒细胞 Fc?R 依赖性而非补体依赖性组织损伤需要 Vav 和 Rac 蛋白,4) 定义了 Mac-1 在触发中性粒细胞弹性蛋白酶释放和随后的出血性血管炎中的作用体内,通过激活 src 和 syk 激酶,5) 证明 Mac-1 对中性粒细胞的关键作用两个额外的补体依赖性模型,大疱性类天疱疮和血栓性肾小球肾炎当前的应用建立在这些发现的基础上,目的是描述与补体 C3 介导的组织损伤和宿主防御相关的中性粒细胞吞噬机制。导致 Mac-1 与其靶标结合的信号以及将 Mac-1 与下游效应器功能联系起来的信号。在 Aim II 中,我们将进一步描述 Vav 的机制。我们还将阐明 Vav 和 Rac 在自身免疫性溶血性贫血模型中巨噬细胞中 IgG 或补体介导的吞噬作用中的作用。导致更好地理解将调理受体与特定吞噬细胞细胞毒性功能联系起来的信号通路,这可能有助于设计选择性靶向通路的治疗方法。负责炎症和自身免疫性疾病中的组织损伤,同时最大限度地减少对宿主防御的影响。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Complement component C3 and complement receptor type 3 contribute to the phagocytosis and clearance of fibrillar Aβ by microglia.
补体成分 C3 和补体受体 3 型有助于小胶质细胞对纤维状 Aβ 的吞噬和清除。
- DOI:
- 发表时间:2012-05
- 期刊:
- 影响因子:6.2
- 作者:Fu, Hongjun;Liu, Bin;Frost, Jeffrey L;Hong, Soyon;Jin, Ming;Ostaszewski, Beth;Shankar, Ganesh M;Costantino, Isabel M;Carroll, Michael C;Mayadas, Tanya N;Lemere, Cynthia A
- 通讯作者:Lemere, Cynthia A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tanya N Mayadas其他文献
Tanya N Mayadas的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tanya N Mayadas', 18)}}的其他基金
Neutrophil plasticity in autoimmune disease
自身免疫性疾病中的中性粒细胞可塑性
- 批准号:
10569637 - 财政年份:2020
- 资助金额:
$ 35.94万 - 项目类别:
Neutrophil plasticity in autoimmune disease
自身免疫性疾病中的中性粒细胞可塑性
- 批准号:
10326852 - 财政年份:2020
- 资助金额:
$ 35.94万 - 项目类别:
TNFR2 Regulation of Leukocyte Recruitment in Glomerulonephritis
肾小球肾炎中白细胞募集的 TNFR2 调节
- 批准号:
8821615 - 财政年份:2014
- 资助金额:
$ 35.94万 - 项目类别:
TNFR2 Regulation of Leukocyte Recruitment in Glomerulonephritis
肾小球肾炎中白细胞募集的 TNFR2 调节
- 批准号:
9456733 - 财政年份:2014
- 资助金额:
$ 35.94万 - 项目类别:
cAMP Control of Endothelial Barrier and T Cell Migration
cAMP 控制内皮屏障和 T 细胞迁移
- 批准号:
7753048 - 财政年份:2009
- 资助金额:
$ 35.94万 - 项目类别:
Endothelia mechanisms of leukocyte accumulation in glomerulonephritis
肾小球肾炎白细胞积聚的内皮机制
- 批准号:
7903751 - 财政年份:2009
- 资助金额:
$ 35.94万 - 项目类别:
Endothelia mechanisms of leukocyte accumulation in glomerulonephritis
肾小球肾炎白细胞积聚的内皮机制
- 批准号:
7620123 - 财政年份:2007
- 资助金额:
$ 35.94万 - 项目类别:
Endothelia mechanisms of leukocyte accumulation in glomerulonephritis
肾小球肾炎白细胞积聚的内皮机制
- 批准号:
7322748 - 财政年份:2007
- 资助金额:
$ 35.94万 - 项目类别:
Mac-1 (CR3) and Fc gamma receptors in immune-mediated neutrophil cytotoxicity
Mac-1 (CR3) 和 Fc gamma 受体在免疫介导的中性粒细胞细胞毒性中的作用
- 批准号:
8209095 - 财政年份:2003
- 资助金额:
$ 35.94万 - 项目类别:
相似国自然基金
氮杂环丙烷基聚多硫化物可逆粘合剂的分子设计与制备
- 批准号:22378080
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
多酚功能化壳聚糖基组织粘合剂构建及其能量耗散机制探究
- 批准号:82302389
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
聚电解质络合作用调控的高初黏性大豆蛋白粘合剂构建及增强机制研究
- 批准号:52303059
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于短肽诱导蚕丝蛋白组装的可控粘附生物粘合剂的制备及粘附性能研究
- 批准号:52303272
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
负载MUR仿生脂质体粘合剂靶向调控荷菌巨噬细胞IFI204/ARMCX3/Caspase-11焦亡抑制创伤性骨髓炎发生的机制研究
- 批准号:82372421
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
相似海外基金
Mac-1 (CR3) and Fc gamma receptors in immune-mediated neutrophil cytotoxicity
Mac-1 (CR3) 和 Fc gamma 受体在免疫介导的中性粒细胞细胞毒性中的作用
- 批准号:
8209095 - 财政年份:2003
- 资助金额:
$ 35.94万 - 项目类别:
Mac-1 (CR3) and Fc gamma receptors in immune-mediated neutrophil cytotoxicity
Mac-1 (CR3) 和 Fc gamma 受体在免疫介导的中性粒细胞细胞毒性中的作用
- 批准号:
7756635 - 财政年份:2003
- 资助金额:
$ 35.94万 - 项目类别:
Mac-1 (CR3) and Fc gamma receptors in immune-mediated neutrophil cytotoxicity
Mac-1 (CR3) 和 Fc gamma 受体在免疫介导的中性粒细胞细胞毒性中的作用
- 批准号:
8010833 - 财政年份:2003
- 资助金额:
$ 35.94万 - 项目类别:
Mac-1 (CR3) and Fc gamma receptors in immune-mediated neutrophil cytotoxicity
Mac-1 (CR3) 和 Fc gamma 受体在免疫介导的中性粒细胞细胞毒性中的作用
- 批准号:
7582061 - 财政年份:2003
- 资助金额:
$ 35.94万 - 项目类别:
Mac-1 (CR3) and Fc gamma receptors in immune-mediated neutrophil cytotoxicity
Mac-1 (CR3) 和 Fc gamma 受体在免疫介导的中性粒细胞细胞毒性中的作用
- 批准号:
8209095 - 财政年份:2003
- 资助金额:
$ 35.94万 - 项目类别: